United Therapeutics Corporation Forecast and Stock Analysis
Technical UTHR stock analysis for April 22, 2019.
United Therapeutics Corporation fell by -1.49% in the last day from $100.34 to $98.84 and has now fallen 5 days in a row. The price has fallen in 8 of the last 10 days and is down by -18.19% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -84 329 shares and in total 432 428 shares bought and sold for approximately $42.74 million.
Close price at the end of the last trading day (Monday, 22nd Apr 2019) of the UTHR stock was $98.84. This is 1.49% less than the trading day before Thursday, 18th Apr 2019.
During day the stock fluctuated 2.87% from a day low at $98.18 to a day high of $101.00.
30 day high of the UTHR stock price was $122.17 and low was $98.18.
90 day high was $128.94 and low was $98.18.
52 week high for the United Therapeutics Corporation - $130.00 and low - $98.18.
United Therapeutics Corporation has broken the wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($106.93) are considered to be a "second chance" to get out. According to the fan-theory $91.31 will represent the new bottom line of the next trend, but it is far too early to say this for certain.
There are few to none technical positive signals at the moment. United Therapeutics Corporation holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $104.66 and $114.10. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Friday April 05, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSI14 is 15 and the stock is extremely oversold on RSI14, but some stocks may continue to fall despite the high chance of a correction up. The low RSI lowers the general risk and the stock should be considered if other technical requirements like liquidity and risk-reward are meet.
Support & Resistance
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.82 between high and low, or 2.87%. For the last week, the stock has had a daily average volatility of 3.39%.
United Therapeutics Corporation is overbought on RSI14 (15). Some stocks may go long and hard while being overbought on RSI, but overbought increases the general risk as higher volatility could be expected, and at some level the stock will have a reaction back to gain new strength.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Strong Sell Candidate
United Therapeutics Corporation holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|UTHR $98.84 ($-1.50 -1.49%)|
UTHR is down $1.50 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for UTHR based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the UTHR analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us